RxDoctor Payments Data

Ronald Singer, MD

Orthopaedic Surgery · Charlotte, NCNPI 1023091444

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Smith+Nephew at 32.7% of the total. Reporting peaked in 2019 at $162,128 and has fallen 99.7% since, to $409 in 2025. Among orthopaedic surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$378,930in general payments, 2019–2025

Across 461 payments — averaging $821.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$124K
  • Medacta USA, Inc.$108K
  • Techmah Medical, LLC$80K
  • Avanos Medical$63K
  • Lima USA, Inc.$2K
  • Next Science LLC$2K
  • plus $880 from 9 others
$225in research payments, 2019–2025

Across 1 payment — averaging $225.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Next Science LLC$225

What the payments were for

  • Consulting fees$186,87749%
  • Speaking & faculty fees$111,62129%
  • Travel & lodging$64,86917%
  • Food & beverage$15,5624%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$378,930 in reported general payments places this provider in the 95th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$506,341
Medicare patients
695
Services billed
5,197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl352$2,326
Meloxicam689$1,717
Tramadol Hcl403$1,298
Cephalexin383$770
Celecoxib31$599
Gabapentin96$571
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$474
Diclofenac Sodium38$419
Pregabalin54$371
Ondansetron Hcl25$99
Clindamycin Hcl80$84
Methylprednisolone17$64

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →